Table 3.
Results of multivariable multi-level logistic regression models of EQ-5D dimensions (no problem versus problem (moderate or extreme)) for the full population (n = 285)
| Mobility | Self-care | Usual activities | Pain/Discomfort | Anxiety/Depression | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Constant | 0.02 (0.00–5.08) | 0.167 | 0.12 (0.02–0.57) | 0.008 | 0.01 (0.00–2.27) | 0.099 | 0.54 (0.28–1.06) | 0.167 | 45.09 (0.23–89.84) | 0.159 |
| Intervention group | 0.72 (0.35–1.47) | 0.365 | 1.25 (0.66–2.34) | 0.437 | 0.86 (0.44–1.67) | 0.656 | 1.18 (0.71–1.94) | 0.525 | 0.69 (0.34–1.41) | 0.312 |
| Time (reference: discharge) | ||||||||||
| 1 month | 0.75 (0.43–1.30) | 0.306 | 0.78 (0.47–1.28) | 0.318 | 0.82 (0.48–1.41) | 0.467 | 0.99 (0.64–1.53) | 0.960 | 0.81 (0.49–1.35) | 0.433 |
| 6 months | 1.12 (0.63–1.98) | 0.707 | 0.39 (0.23–0.67) | 0.001 | 1.02 (0.59–1.79) | 0.081 | 1.13 (0.72–1.77) | 0.593 | 1.36 (0.81–2.28) | 0.242 |
| 12 months | 1.73 (0.95–3.16) | 0.075 | 0.78 (0.46–1.34) | 0.366 | 1.08 (0.62–1.90) | 0.784 | 1.69 (1.05–2.71) | 0.031 | 1.07 (0.63–1.82) | 0.797 |
| Study ward 1 | NS | 2.42 (1.04–5.66) | 0.041 | 3.27 (1.43–7.47) | 0.005 | NA | NS | |||
| Age when includeda | 1.08 (1.02–1.15) | 0.010 | NS | 1.08 (1.02–1.14) | 0.013 | NA | 0.93 (0.87–0.99) | 0.025 | ||
| Sex Female | NA | NA | NS | 2.04 (1.22–3.40) | 0.007 | 2.59 (1.24–5.41) | 0.011 | |||
| Level of education > 12 years | NA | NA | NS | NA | NA | |||||
| Home-dwelling before included | 0.07 (0.01–0.46) | 0.006 | 0.12 (0.03–0.42) | 0.001 | 0.03 (0.00–0.22) | 0.001 | NA | NS | ||
| Living alone before included | NS | NS | NS | NA | NA | |||||
| Home-care services | 6.79 (2.95–15.64) | < 0.001 | 12.44 (5.71–27.10) | < 0.001 | 4.77 (2.18–10.43) | < 0.001 | NS | NS | ||
| Number of medications totala | 1.11 (1.02–1.20) | 0.012 | 1.10 (1.03–1.17) | 0.003 | 1.24 (1.14–1.34) | < 0.001 | 1.12 (1.07–1.18) | < 0.001 | 1.09 (1.01–1.17) | 0.023 |
| Handling own medications | NS | NS | NS | NA | 0.34 (0.15–0.76) | 0.009 | ||||
| Multidose adherence aid | NS | NS | NS | NS | NS | |||||
| Hypertension | NA | NA | NA | NA | NA | |||||
| Asthma or COPD | NA | NS | NS | NS | NA | |||||
| Atrial fibrillation | NS | NS | NS | NA | 2.58 (1.17–5.70) | 0.019 | ||||
| Diabetes | NS | NS | NS | NA | NS | |||||
| Heart failure | NS | NS | 0.36 (0.13–0.97) | 0.043 | NA | NS | ||||
| Renal failure | NA | NA | NA | NA | NA | |||||
| Anxiety / depression | NA | NS | NS | NS | 19.94 (5.35–74.39) | < 0.001 | ||||
| Dementia | NA | NS | NA | 0.15 (0.28–0.06) | 0.007 | NA | ||||
| Charlson Comorbidity Indexb | NS | NS | NS | NA | NA | |||||
COPD Chronic Obstructive Pulmonary Disease; OR odds ratio; CI confidence interval; NS not significant in multivariate regression; NA not applicable based on univariate regression
a Continuous varable
b Tested separately from other comorbidities
Results in bold are statistically significant